Yesintek is the latest Stelara biosimilar to gain FDA approval and it will be available in February 2025.
If granted, Tremfya will be approved to treat children ages six and under with severe plaque psoriasis and children ages five ...
Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback